Association of Free Thyroxine with Progression-Free Survival in Intermediate and High Risk Differentiated Thyroid Cancer

甲状腺癌 游离甲状腺素 肿瘤科 内科学 癌症 医学 联想(心理学) 甲状腺 内分泌学 心理学 甲状腺功能 心理治疗师
作者
Raisa Ghosh,Sungyoung Auh,Sriram Gubbi,Padmasree Veeraraghavan,Craig Cochran,Leila Shobab,Mark L. Urken,Kenneth D. Burman,Leonard Wartofsky,Joanna Kłubo-Gwieździńska
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [Oxford University Press]
被引量:1
标识
DOI:10.1210/clinem/dgae537
摘要

Abstract Context Supraphysiologic T4 doses are used in intermediate- and high-risk patients with differentiated thyroid cancer (IR/HR-DTC) to suppress tumor progression by TSH. However, preclinical data suggest that T4 can also act as a growth stimulus for cancer, but there is no clinical evidence supporting this claim. Objective We analyzed the association between free T4 (FT4) and progression-free survival (PFS) in patients with IR/HR-DTC. Methods This longitudinal cohort study, approved by multi-institutional review board, included patients with IR/HR-DTC treated uniformly with total thyroidectomy, radioiodine, and TSH suppression therapy, with at least 3 TSH and FT4 values available. Association between FT4 and PFS at landmarks 6, 12, and 18 months was assessed by Kaplan-Meier survival curves, whereas competing risks were assessed through Cox proportional hazards model. Results From 739 screened patients, 382 met the inclusion criteria and were characterized by a median age of 46 (34-59) years, 64.1% women, and treated with a median radioiodine dosage of 159 (110-410) mCi. During follow up of 7.1 (3.4-12.7) years, 34.6% experienced disease progression. Elevated FT4, observed in 29.3% of patients, was not associated with worse PFS (hazard ratio [HR], 0.9; CI, 0.54-1.5; P = .69), whereas age (HR, 1.02; CI, 1.004-1.04; P = .01), tumor size (HR, 1.15; CI, 1.04-1.28; P = .01) and metastases to the lateral neck lymph nodes (HR, 2.9; CI, 1.7-4.74; P < .001), bones (HR, 4.87; CI, 1.79-13.3; P = .002), and brain (HR, 5.56; CI; 2.54-12.2; P < .001) were associated with shorter PFS. Conclusion Contrary to preclinical evidence, elevated FT4 levels do not affect PFS in patients with IR/HR-DTC.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Akim的应助被meng采纳,获得10
刚刚
爆米花的应助被无限的芷云采纳,获得30
1秒前
CZF完成签到,获得积分10
1秒前
Orange的应助被科研家采纳,获得10
1秒前
哈哈发布了新的文献求助20
1秒前
田様的应助被吃花花采纳,获得10
1秒前
研友_VZG7GZ的应助被Postgraduate-Z采纳,获得10
1秒前
实验室发布了新的文献求助10
2秒前
磕了送完成签到,获得积分10
2秒前
哈哈完成签到,获得积分10
2秒前
ZZXLX完成签到,获得积分10
2秒前
坚定背包发布了新的文献求助10
2秒前
3秒前
科研民工完成签到,获得积分10
3秒前
3秒前
Charison完成签到,获得积分10
3秒前
wenyu_Tan完成签到,获得积分10
4秒前
4秒前
4秒前
长情的语琴完成签到,获得积分10
4秒前
ttt发布了新的文献求助10
4秒前
cdercder的应助被碧蓝山水采纳,获得10
4秒前
李魏完成签到,获得积分10
5秒前
xxcub发布了新的文献求助10
5秒前
灵巧冰露发布了新的文献求助10
5秒前
5秒前
凯鐹给合着的求助进行了留言
5秒前
5秒前
5秒前
vision0000发布了新的文献求助10
6秒前
4645完成签到,获得积分10
6秒前
helf_tender完成签到,获得积分10
6秒前
无花果的应助被mani采纳,获得10
6秒前
PDIF-CN2发布了新的文献求助10
6秒前
6秒前
自觉的涵易完成签到,获得积分10
7秒前
zqy关注了科研通微信公众号
7秒前
8秒前
FashionBoy的应助被落叶采纳,获得10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8169380
求助须知:如何正确求助?哪些是违规求助? 9562400
关于积分的说明 21765715
捐赠科研通 7760957
什么是DOI,文献DOI怎么找? 3430315
关于科研通互助平台的介绍 2554132
邀请新用户注册赠送积分活动 2475010